Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...

A major study suggests that the cardiovascular benefits of certain diabetes medications can fade within months after stopping ...

Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those ...

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and ...

An eye-opening study from the VA Saint Louis Healthcare System shows what quitting weight-loss drugs can do to the heart.

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

March 20 () - Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis ...

A recent research revealed that discontinuing GLP-1 drugs for diabetes may increase the risk of cardiac events, stroke, and ...

Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact on survival among people living with multiple myeloma, ...

Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...